Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies |
Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma | Brazil | NCT05541341 | |
|
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids |
Primary Immune Thrombocytopenia | Phase3 |
Argentina Australia Austria Belgium China Czechia France Germany Hungary India Italy Japan Korea, Republic of Malaysia Mexico Netherlands Norway Philippines Romania Singapore Spain Taiwan Thailand Turkey United Kingdom United States View All
|
NCT05653219 |
|
Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma. |
Melanoma | Turkey | NCT04961619 | |
|
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
Metastatic Neuroendocrine Prostate Cancer | Phase1 |
France Spain United States |
NCT06379217 |
|
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis |
Multiple Sclerosis | Phase4 |
Germany United Kingdom United States |
NCT06444113 |
|
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria |
Paroxysmal Nocturnal Hemoglobinuria | Phase3 |
France Germany Italy Spain United Kingdom United States View All
|
NCT04747613 |
|
The Gilenya Pregnancy Registry |
Multiple Sclerosis |
Argentina Australia Austria Belgium Brazil Canada Colombia Cyprus Czechia Denmark Finland France Germany Greece Hungary Ireland Israel Italy Lebanon Mexico Netherlands Poland Portugal Romania Russian Federation Saudi Arabia Slovakia Slovenia Spain Sweden Switzerland United Arab Emirates United Kingdom United States View All
|
NCT01285479 | |
|
Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum |
PIK3CA-related Overgrowth Spectrum (PROS) | Phase2 |
Canada France Germany Italy Netherlands Spain Switzerland United Kingdom United States View All
|
NCT04589650 |
|
First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers |
Healthy Volunteers | Phase1 | United Kingdom | NCT05275855 |
|
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. |
Oligometastatic Prostate Cancer (OMPC) | Phase3 |
Australia Austria Belgium Canada Czechia France Hungary Israel Italy Japan Singapore Slovakia Spain Switzerland Taiwan United States View All
|
NCT05939414 |